Literature DB >> 24935676

Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.

Jonathan M Eby1, Hee-Kap Kang, Jared Klarquist, Shilpak Chatterjee, Jeffrey A Mosenson, Michael I Nishimura, Elizabeth Garrett-Mayer, B Jack Longley, Victor H Engelhard, Shikhar Mehrotra, I Caroline Le Poole.   

Abstract

To generate a mouse model of spontaneous epidermal depigmentation, parental h3TA2 mice, expressing both a human-derived, tyrosinase-reactive T-cell receptor on T cells and the matching HLA-A2 transgene, were crossed to keratin 14-promoter driven, stem cell factor transgenic (K14-SCF) mice with intra-epidermal melanocytes. In resulting Vitesse mice, spontaneous skin depigmentation precedes symmetrical and sharply demarcated patches of graying hair. Whereas the SCF transgene alone dictates a greater retinoic acid receptor-related orphan receptor gamma (RORγt)(+) T-cell compartment, these cells displayed markedly increased IL-17 expression within Vitesse mice. Similar to patient skin, regulatory T cells were less abundant compared with K14-SCF mice, with the exception of gradually appearing patches of repigmenting skin. The subtle repigmentation observed likely reflects resilient melanocytes that coexist with skin-infiltrating, melanocyte-reactive T cells. Similar repigmenting lesions were found in a different TCR transgenic model of vitiligo developed on an SCF transgenic background, supporting a role for SCF in repigmentation.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-17; T-cell receptor; mouse model; pigmentation; stem cell factor; vitiligo

Mesh:

Substances:

Year:  2014        PMID: 24935676      PMCID: PMC4470702          DOI: 10.1111/pcmr.12284

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  62 in total

1.  FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.

Authors:  Lise Mette Gjerdrum; Anders Woetmann; Niels Odum; Christoffer Hother; Regitze Henrik-Nielsen; Robert Gniadecki; Elisabeth Ralfkiaer
Journal:  Eur J Haematol       Date:  2008-03-10       Impact factor: 2.997

2.  Epidermal stem cell factor augments the inflammatory response in irritant and allergic contact dermatitis.

Authors:  Eric L Carter; Sean O'Herrin; Carla Woolery; B Jack Longley
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

Review 3.  Update on skin repigmentation therapies in vitiligo.

Authors:  Rafael Falabella; Maria I Barona
Journal:  Pigment Cell Melanoma Res       Date:  2008-11-27       Impact factor: 4.693

Review 4.  Clinical practice. Vitiligo.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  N Engl J Med       Date:  2009-01-08       Impact factor: 91.245

Review 5.  Physiological factors that regulate skin pigmentation.

Authors:  Yuji Yamaguchi; Vincent J Hearing
Journal:  Biofactors       Date:  2009 Mar-Apr       Impact factor: 6.113

Review 6.  Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation.

Authors:  Prabir Ray; Nandini Krishnamoorthy; Anuradha Ray
Journal:  Cell Cycle       Date:  2008-09-07       Impact factor: 4.534

7.  Evidence that the bulge region is a site of relative immune privilege in human hair follicles.

Authors:  K C Meyer; J E Klatte; H V Dinh; M J Harries; K Reithmayer; W Meyer; R Sinclair; R Paus
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

8.  HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.

Authors:  Cecele J Denman; James McCracken; Vidhya Hariharan; Jared Klarquist; Kepa Oyarbide-Valencia; José A Guevara-Patiño; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

9.  Stem cell factor rescues tyrosinase expression and pigmentation in discreet anatomic locations in albino mice.

Authors:  Jillian C Vanover; Malinda L Spry; Laura Hamilton; Kazumasa Wakamatsu; Shosuke Ito; John A D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-04       Impact factor: 4.693

10.  Immunosuppression may be present within condyloma acuminata.

Authors:  Caroline Le Poole; Cecele J Denman; Jack L Arbiser
Journal:  J Am Acad Dermatol       Date:  2008-12       Impact factor: 11.527

View more
  7 in total

Review 1.  The role of IL-17 in vitiligo: A review.

Authors:  Rasnik K Singh; Kristina M Lee; Ivan Vujkovic-Cvijin; Derya Ucmak; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Tina Bhutani; Maria Wei; Wilson Liao
Journal:  Autoimmun Rev       Date:  2016-01-21       Impact factor: 9.754

2.  Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.

Authors:  Nathaniel B Goldstein; Maranke I Koster; Kenneth L Jones; Bifeng Gao; Laura G Hoaglin; Steven E Robinson; Michael J Wright; Smaranda I Birlea; Abigail Luman; Karoline A Lambert; Yiqun G Shellman; Mayumi Fujita; William A Robinson; Dennis R Roop; David A Norris; Stanca A Birlea
Journal:  J Invest Dermatol       Date:  2017-10-17       Impact factor: 8.551

Review 3.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

4.  AHR promoter variant modulates its transcription and downstream effectors by allele-specific AHR-SP1 interaction functioning as a genetic marker for vitiligo.

Authors:  Xiaowen Wang; Kai Li; Ling Liu; Qiong Shi; Pu Song; Zhe Jian; Sen Guo; Gang Wang; Chunying Li; Tianwen Gao
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

5.  Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome.

Authors:  Yuna Chai; Yusheng Huang; Hongmei Tang; Xing Tu; Jianbo He; Ting Wang; Qingye Zhang; Fen Xiong; Detang Li; Zhenwen Qiu
Journal:  Exp Ther Med       Date:  2017-02-20       Impact factor: 2.447

6.  Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.

Authors:  Zhussipbek Mukhatayev; Emilia R Dellacecca; Cormac Cosgrove; Rohan Shivde; Dinesh Jaishankar; Katherine Pontarolo-Maag; Jonathan M Eby; Steven W Henning; Yekaterina O Ostapchuk; Kettil Cedercreutz; Alpamys Issanov; Shikhar Mehrotra; Andreas Overbeck; Richard P Junghans; Joseph R Leventhal; I Caroline Le Poole
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

7.  A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte.

Authors:  Daoming Chen; Zijian Xu; Jun Cui; Ting Chen
Journal:  Cell Regen       Date:  2022-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.